When a race ends, most people focus on the result. Where you finished.Who won.What went wrong or right. But in racing, the real work starts after the checkered flag. Because the result tells you what happened. Data tells you why

Leadership is often discussed in terms of strategy, decision-making, and results. Those matter. But there’s another responsibility that doesn’t get as much attention, and it shapes everything else: Setting the tone. Whether it’s intentional or not, leaders establish the environment in which their teams operate. How they communicate, how they respond under pressure, what they tolerate, what they prioritize—all of it sends a signal. And over time, those signals become cul

Most people think progress in cancer research happens in big moments. A breakthrough. A headline. A new treatment. What they don’t see is everything that happens before that. The years of work. The failed experiments. The collaboration across institutions. The early ideas that don’t yet have enough data to qualify for traditional funding. That’s where a lot of the real progress starts. And it’s where cancer research philanthropy can make a meaningful difference.

When people talk about the FDA approval process, the conversation usually splits in two directions. One side argues it takes too long. The other argues it exists for a reason. Both are right. The challenge isn’t choosing between speed and safety. It’s understanding that the FDA approval process is designed to manage risk in a system where the consequences of getting it wrong are significant. That makes the balance more complicated than most headlines suggest.

The race almost ended before it started. There was a 10-car pileup before we even got going. In this series, that’s not something you expect to see. Cars were checking up. The field compressed quickly. There was nowhere to go, and everything happened at once. In moments like that, you don’t have time to think through options. You react.

There’s a psychological reason busyness is so appealing. Responding to messages, attending meetings, and resolving immediate issues creates the sense that work is getting done. These activities are visible and measurable. They create the appearance of momentum. But they often focus on short-term inputs rather than long-term outcomes. Many leaders find themselves spending entire days reacting rather than directing. The schedule fills itself with operational issues, leavi

When people hear about a cancer research breakthrough, the story often sounds simple. A discovery is announced. A new therapy shows promise. A headline declares progress. But what most people don’t see behind cancer research breakthroughs is the long, demanding path that leads to that moment. Scientific progress rarely arrives in a single dramatic leap. It comes through years of incremental work, careful experimentation, and persistence from researchers who are trying to a

People see the speed. They see the pass in Turn 1. They see the podium photo. They see the lap time. What they don’t see is the mental preparation in motorsport that makes any of it possible. In racing, the margin for error is measured in inches and milliseconds. You are operating at high speed, surrounded by competitors who are equally skilled, equally aggressive, and equally committed to winning. Physical preparation matters. Engineering matters. Strategy matters.

For more than a decade, policymakers have promoted value-based care as the future of American healthcare. Pay for outcomes. Reward quality over volume.Lower costs while improving patient care. On paper, it makes sense. In theory, it aligns incentives. In practice? The results are more complicated. If we’re serious about healthcare reform, we need to ask a straightforward question: Is value-based care actually delivering measurable results, or are we just relabeling the